ClinicalTrialsFinder

Indication of the Parent Protocol Clinical Trials in London, Ontario

1 recruitingLondon, Ontario, Canada

Showing 1–1 of 1 trials

Recruiting
Phase 3

Remibrutinib Open Label Roll-over Post-trial Access Protocol

Indication of the Parent Protocol
Novartis Pharmaceuticals212 enrolled1 locationNCT07456891